State Of Alaska, Department Of Revenue Agios Pharmaceuticals, Inc. Transaction History

State Of Alaska, Department Of Revenue

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 02, 2019	SELL	$32.4 - $49.58 $191,160 - $292,522	-5,900 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$46.17 - $68.1 $1,385 - $2,042	30 Added 0.51%	5,900 $293,000
Q1 2019 Apr 09, 2019	SELL	$45.92 - $67.67 $14,189 - $20,910	-309 Reduced 5.0%	5,870 $394,000
Q4 2018 Jan 10, 2019	BUY	$42.73 - $76.53 $1,837 - $3,290	43 Added 0.7%	6,179 $284,000
Q3 2018 Oct 09, 2018	BUY	$71.67 - $91.95 $12,613 - $16,183	176 Added 2.95%	6,136 $472,000
Q2 2018 Jul 10, 2018	BUY	$73.22 - $99.55 $107,633 - $146,338	1,470 Added 32.74%	5,960 $501,000
Q1 2018 Apr 19, 2018	BUY	$59.83 - $86.53 $101,112 - $146,235	1,690 Added 60.36%	4,490 $366,000
Q4 2017 Jan 19, 2018	BUY	$52.12 - $72.33 $145,936 - $202,524	2,800	2,800 $160,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.34B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.